NCT05241912

Brief Summary

This is a randomized double-blinded study to investigate in which the groups are designated as the control group and the goal-directed fluid therapy group to further evaluate significant differences in rate of complications during burn surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 6, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 16, 2022

Completed
12 days until next milestone

Study Start

First participant enrolled

February 28, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

February 16, 2022

Status Verified

January 1, 2022

Enrollment Period

1.3 years

First QC Date

February 6, 2022

Last Update Submit

February 6, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Complication

    perioperative complications

    One week after operation

Study Arms (2)

Control group

NO INTERVENTION

Intraoperative fluid management: administration of 6-10 ml/kg/hr of crystalloid solution.

Goal-directed fluid group

EXPERIMENTAL

Intervention: administration of dobutamine 0.01 - 0.04 U/min after induction of anesthesia. Intraoperative fluid management: administration of 2-4 ml/kg/hr of crystalloid solution.

Drug: Dobutamine

Interventions

administration of dobutamine 0.01 - 0.04 U/min after induction of anesthesia to maintain oxygen delivery

Goal-directed fluid group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Severe burn patients

You may not qualify if:

  • Patients or families refuse to sign consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangzhou Red cross hospital

Guangzhou, Guangdong, 510220, China

Location

MeSH Terms

Interventions

Dobutamine

Intervention Hierarchy (Ancestors)

CatecholaminesAminesOrganic ChemicalsPhenethylaminesEthylaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate senior doctor

Study Record Dates

First Submitted

February 6, 2022

First Posted

February 16, 2022

Study Start

February 28, 2022

Primary Completion

June 1, 2023

Study Completion

June 1, 2023

Last Updated

February 16, 2022

Record last verified: 2022-01

Locations